(Q35603920)

9 August 2017

1 reference

title

Old and new cardiovascular risk factors: from unresolved issues to new opportunities (English)

1 reference

9 August 2017

Renke Maas

1

1 reference

9 August 2017

Rainer H Böger

series ordinal

2

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Atherosclerosis. Supplements

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

5-17

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Innate and acquired immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

1 reference

7 January 2021

Platelets in atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Molecular medicine. The cholesterol quartet

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Histopathology of in-stent restenosis in patients with peripheral artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Reliability of causes of death in persons with Type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

The necessary role of the autopsy in cardiovascular epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

What is the real hospital mortality from acute myocardial infarction?. Epidemiological vs clinical view

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Hemodynamic shear stress and its role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

The role of oxidized lipoproteins in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Coronary heart disease, hypercholesterolemia, and atherosclerosis. I. False premises

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Coronary heart disease, hypercholesterolemia, and atherosclerosis. II. Misrepresented data

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Platelet activation in obese women: role of inflammation and oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Obesity, insulin resistance and isolated low high-density-lipoprotein cholesterol in Chinese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

HDL and arteriosclerosis: beyond reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Pulse pressure and endothelial dysfunction in never-treated hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

A prospective study of parental history of myocardial infarction and coronary artery disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Risk factors for coronary artery disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Importance of total life consumption of cigarettes as a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Cigarette smoke-induced endothelium dysfunction: role of superoxide anion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol--the Reykjavik Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effect of food fortification on folic acid intake in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Sirolimus-eluting coronary stents

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Pilot trial of oral rapamycin for recalcitrant restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Vascular smooth muscle cell activation by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

The role of inflammation and infection in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Impact of infectious burden on progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Antioxidants and atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Can antioxidant vitamins materially reduce oxidative damage in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Biomarkers of free radical damage applications in experimental animals and in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Determination of activity of antioxidants in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Radiolabeled Native Low-Density Lipoprotein Injected Into Patients With Carotid Stenosis Accumulates in Macrophages of Atherosclerotic Plaque

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Cardiovascular mortality in children and young adults with end-stage kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

A strategy to reduce cardiovascular disease by more than 80%

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Comorbidity and drug use in cognitively impaired elderly living in long-term care

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Serum cholesterol in young men and subsequent cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Total Serum Cholesterol Levels and Mortality Risk as a Function of Age

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

Increased carotid intima-media thickness in men born in east Finland: a twin study of the effects of birthplace and migration to Sweden on subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900028-X

7 January 2021

10.1016/S1567-5688(03)00028-X

Identifiers

DOI

1 reference

9 August 2017

1 reference